Dow Up 1.30% Nasdaq Up 0.37%

Hemispherx Biopharma, Inc. (HEB)

-NYSE MKT
0.29 Down 0.01(2.95%) Oct 30, 4:00PM EDT
|After Hours : 0.30 Up 0.01 (4.79%) Oct 30, 4:58PM EDT
Prev Close:0.30
Open:0.30
Bid:0.28 x 20000
Ask:0.31 x 800
1y Target Est:3.00
Beta:0.64
Next Earnings Date:N/A
Day's Range:0.23 - 0.31
52wk Range:0.19 - 0.55
Volume:1,572,736
Avg Vol (3m):1,777,990
Market Cap:54.40M
P/E (ttm):N/A
EPS (ttm):-0.10
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for HEB

Comparison

Symbol% ChgMkt Cap
HEBDown 2.95%54.40M
GILDUp 3.16%172.92B
MRKUp 1.98%165.32B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):304.61
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.11
Quarterly EPS Est (Sep-14) :-0.03
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):-0.11

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Hemispherx Biopharma, Inc., a specialty pharmaceutical company, is engaged in the clinical development of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders in the... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback